Caulawon, Janine Kyla .
HRN: 02-15-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2024
CEFUROXIME 500MG (TAB)
06/15/2024
06/21/2024
PO
500mg
Bid
Nsvd Wbc 20
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes